- 基本信息
导师姓名:
|
王朝夫
|
学科代码:
|
1002Z1
|
|
性别:
|
男
|
学科名称:
|
临床病理学
|
培养单位:
|
附属瑞金医院
|
三级学科
|
|
导师类型:
|
博士生导师
|
专业领域名称:
|
临床病理 专业学位
|
联系方式:
|
18917762922
|
专业领域代码:
|
105119
|
邮编:
|
200025
|
邮箱地址:
|
wangchaofu@126.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
|
上海交通大学医学院附属瑞金医院 病理科行政主任
|
《诊断学理论与实践杂志》副主编
|
《临床与实验病理学杂志》编委
|
《中国骨与关节杂志》编委
|
《中华病理学杂志》审稿人
|
《中国癌症杂志》审稿人
|
《中华解剖与临床杂志》特约审稿人
|
中华医学会病理学会上海市抗癌协会头颈肿瘤专业委员会委员
|
中华医学会病理学分会肉瘤学组委员
|
中华医学会病理学分会泌尿学组委员
|
- 科研项目
21ZR1440100 | LncRNA TCLlnc1激活TGF-β通路促进血管免疫母细胞性T细胞淋巴瘤进展的机制及预后价值研究 | 上海市科委基金 |
2021-07~2024-08
|
20万元
| 课题负责人 |
201540280 | miR-145、miR-224、miR-708在前列腺癌不同Gleason分级中的差异表达及其与预后相关关系研究 | 上海市卫计委面上项目 |
2016-01~2018-12
|
5万元
| 课题负责人 |
无 | 无 | 瑞金医院资助 |
2015-11~2018-11
|
50万元
| 课题负责人 |
ZZZZ1302-4 | 基因标志物,miRNA在前列腺癌不同Gleason分级中的差异性表达及其与预后相关关系的研究 | 上海市重中之重临床重点学科建设项目子课题 |
2014-11~2016-11
|
10万元
| 课题负责人 |
- 学术论文
,Jing Xie, Lei Zhao,Xiaochun Fei,Heng Zhang,Yun Tan,Xiu Nie,Luting Zhou,Zhenhua Liu,Yong Ren,Ling Yuan,Yu Zhang,Jinsheng
Zhang,Liwei Liang,Xinwei Chen,Xin Liu,Peng Wang,Xiao Han,Xiangqin Weng,Ying Chen,Ting Yu,Xinxin Zhang,Jun Cai,Rong Chen,Zhengli Shi, Xiuwu
Bian
|
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
|
EBioMedicine
|
2020
|
2020.57
|
Zhou J, Zhang D, Li W, Zhou L, Xu H, Zheng S,
|
Primary adrenal schwannoma: a series of 31 cases emphasizing their clinicopathologic features and favorable prognosis
|
Endocrine
|
2019
|
Epub ahead of print
|
Zhou L, Xu H, Zhou J, Dong L, Zhang P, Yang X,
|
Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis
|
Diagn Pathol
|
2019
|
14(1):34
|
Zhou J, Zhou L, Wu S, Li R, Yang X, Xu H, Zheng S, Wang A,
|
Clinicopathologic Study of Calcifying Fibrous Tumor Emphasizing Different Anatomical Distribution and Favorable Prognosis
|
Biomed Res Int
|
2019
|
2019:5026860
|
Zhou L, Xu H, Zhou Y, Zhou J, Zhang P, Yang X,
|
Biphasic squamoid alveolar renal carcinoma with positive CD57 expression: A clinicopathologic study of three cases.
|
Pathol Int
|
2019
|
Epub ahead of print
|
Ji MM, Huang YH, Huang JY,, Fu D, Liu H, Liu F, Leboeuf C, Wang L, Ye J, Lu YM, Janin A, Cheng S, Zhao WL
|
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
|
Haematologica
|
2018
|
103(4):679-687
|
Zhang PP, Wang YQ, Weng WW, Nie W, Wu Y, Deng Y, Wei P, Xu MD,
|
Linc00152 promotes Cancer Cell Proliferation and Invasion and Predicts Poor Prognosis in Lung adenocarcinoma
|
J Cancer
|
2017
|
8(11):2042-2050
|
Wu Y, Wang Y, Weng W W,Zhang QY, Yang XQ, Gan HL, Yang YS, Zhang PP, Sun MH, Xu MD,
|
A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls
|
Oncogenesis
|
2016
|
5(2):e192
|
Jiang L, Wang W, Li G, Sun C, Ren Z, Sheng H, Gao H,, Yu H.
|
High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma
|
Cancer Chemother Pharmacol
|
2016
|
78(2):333-9
|
Yang XQ, Wu Y, Gan HL, Wang T,
|
Clear cell renal cell carcinoma with rhabdoid differentiation: report of 10 Chinese cases supporting a distinctive variant.
|
Int J Clin Exp Pathol
|
2016
|
9(1):129-137
|
Yu H, Li H, Cui Y, Xiao W, Dai G, Huang J,
|
The mRNA level of MLH1 in peripheral blood is a biomarker for the diagnosis of hereditary nonpolyposis colorectal cancer
|
Am J Cancer Res
|
2016
|
6(5):1135-40
|
Wu Y, Tan C, Weng W W,Deng Y, Zhang QY, Yang XQ, Gan HL, Wang T, Zhang PP, Xu MD, Wang Y Q,
|
Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma
|
Am J Cancer Res
|
2016
|
6(2):285-299
|
Sun JJ, Wu Y, Lu YM, Zhang HZ, Wang T, Yang XQ, Sun MH,
|
Immunohistochemistry and Fluorescence In Situ Hybridization Can Inform the Differential Diagnosis of Low-Grade Noninvasive Urothelial Carcinoma with an Inverted Growth Pattern and Inverted Urothelial Papilloma
|
PLOS ONE.
|
2015
|
10(7):e0133530
|
Wu Y, Wang T, Zhang PP, Yang X, Wang J,
|
Extraneural hemangioblastoma of the kidney: the challenge for clinicopathological diagnosis
|
J CLIN PATHOL
|
2015
|
68(12):1020-1025
|
Zhu Y, Yang X, Han C, Dai B, Zhang HL, Shi GH,, Ye DW.
|
Pathological Features of Localized Prostate Cancer in China: A Contemporary Analysis of Radical Prostatectomy Specimens
|
PLOS ONE
|
2015
|
10(3):e0121076
|
Dong F,, Farris AB, Wu S, Lee H, Olumi AF, McDougal WS, Young RH, Wu CL.
|
Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system
|
AM J SURG PATHOL
|
2012
|
36(6):838-43
|
|